相关实验视频

Updated: Jun 22, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

使用β2-微球蛋白去除列的治疗性阿费雷西斯减少循环瘤细胞数量

Yasuo Komura¹, Shintarou Kimura², Ayana Takaura¹

¹Rinku Medical Clinic, 2F Medical Rinku Port, 3-41 Rinku Ouraiminami, Osaka 598-0047, Japan.

Journal of personalized medicine

|June 27, 2024

概括

这项研究表明,Filtor是一种新的β2-微球蛋白 (β2M) 清除柱,有效降低β2M水平和循环瘤细胞 (CTC). 这表明Filtor可以预防癌症转移和复发.

科学领域:

在瘤学瘤学.
腎臟病學 (nephrology) 是一種醫學專業.
生物医学工程生物医学工程

背景情况:

血清β2-微球蛋白 (β2M) 的升高表明功能受损,并与癌症和自身免疫性疾病等疾病有关.
高水平的β2M可以通过诱导上皮层-介质细胞过渡 (EMT) 来促进癌症转移.
针对β2M治疗癌症的治疗价值尚不清楚.

研究的目的:

为了评估Filtor的有效性,一个基于聚甲基甲基酸纤维的β2M去除柱.
确定Filtor是否可以降低β2M水平并抑制癌细胞诱导的EMT和转移.
评估Filtor对循环瘤细胞 (CTC) 的影响,以此衡量转移.

主要方法:

使用Filtor列在三个患有晚期癌症的患者身上进行了治疗性阿菲雷斯.
患者包括那些患有鼻腔神经内分泌癌,结直肠癌和胰腺管道腺癌的患者.
在治疗前和治疗后测量了血清β2M水平和CTC计数.

主要成果:

血清β2M水平和CTC计数显著下降,立即和治疗后4周.
在表后立即观察到CTC计数显著减少,这表明Filtor.直接捕获CTC.
该研究表明β2M和CTCs的成功降低,表明潜在的抗转移效应.

结论:

使用Filtor的治疗性非瑞斯有效降低了血清β2M和CTC计数.
通过直接去除CTCs,Filtor在预防癌症转移和复发方面表现有前途.
用Filtor准β2M代表了癌症治疗中的潜在新策略.

关键词:

在循环中的瘤细胞中.转移转移转移转移复发性复发性复发性治疗性外表症治疗性外表症这是一种β2-微型血球蛋白.

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.